fluorodeoxyglucose f18 has been researched along with Castleman Disease in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.17) | 18.2507 |
2000's | 13 (28.26) | 29.6817 |
2010's | 20 (43.48) | 24.3611 |
2020's | 12 (26.09) | 2.80 |
Authors | Studies |
---|---|
Guan, ZW; Ma, GY | 1 |
Akita, K; Chiba, D; Ito, A; Katayama, H; Katsumata, Y; Kawamorita, N; Kawasaki, Y; Mitsuzuka, K; Miyagi, A; Satake, Y; Shimada, S; Watanabe, M; Yamashita, S | 1 |
Chen, Y; He, L; Jiang, L; Luo, H; Sun, X; Tan, X; Zhang, Q | 1 |
Cai, H; Li, F; Li, L; Xiao, L | 1 |
Cheng, W; Huo, L; Liu, M; Zhou, J; Zhu, W | 1 |
Acevedo Báñez, I; Fernández López, R; Fernández-Rodríguez, P; Jiménez-Hoyuela García, JM; Mohigefer Barrera, J | 1 |
Cheng, X; Ding, J; Hou, G; Huo, L; Jing, H | 1 |
Flamini, MEDM; Flamini, RC; Loureiro, LVM; Verçosa, AFA | 1 |
Dong, D; Li, H; Wang, W; Wen, J | 1 |
Cheng, W; Hou, G; Huo, L; Jiang, Y; Li, F; Zhu, Z | 1 |
Adam, Z; Koukalová, R; Řehák, Z; Selingerová, I; Szturz, P | 1 |
Cheng, X; Hou, G; Li, F; Wang, P | 1 |
Choe, YH; Jeong, JS; Kim, CH; Kim, SR; Lee, YC; Park, HS | 1 |
Hatakenaka, M; Himi, T; Kamekura, R; Takahashi, H; Takano, K; Yajima, R; Yama, N; Yamamoto, M | 1 |
Horger, M; Schwarz, R | 1 |
Dong, A; Lu, J; Wang, Y; Yang, B | 1 |
Hu, Y; Liu, Y; Shi, H | 1 |
Chen, X; Fu, Z; Li, Q; Liu, M; Yang, X | 1 |
Li, F; Luo, Y; Ma, Y; Pan, Q; Wang, L | 1 |
Hotta, M; Minamimoto, R; Nakano, M; Yamashita, H; Yashima, A | 1 |
Li, F; Luo, Y; Ma, Y; Pan, Q; Zhang, X | 1 |
Chang, W; Chung, JK; Kang, KW; Lee, DS; Lee, ES; Lee, WW; Paeng, JC; Park, CM | 1 |
Dong, A; Dong, H; Zuo, C | 1 |
Hiraki, T; Kaieda, H; Komiya, S; Nagano, S; Setoguchi, T; Tashiro, Y; Yamamoto, T; Yokouchi, M; Yonezawa, S | 1 |
Chen, L; Li, F; Ma, Y | 1 |
Hisatomi, K; Ito, M; Iwanaga, N; Izumi, Y; Kawahara, C; Kawakami, A; Kurohama, H; Matsuda, M; Migita, K; Moriwaki, Y; Niino, D; Shigemitsu, Y; Takeshita, H; Yamashita, N | 1 |
Aleman, K; Little, RF; Maass-Moreno, R; Marshall, V; Millo, C; O'Mahony, D; Polizzotto, MN; Steinberg, SM; Uldrick, TS; Whatley, M; Whitby, D; Wyvill, KM; Yarchoan, R | 1 |
Behnia, F; Elojeimy, S; Fajgenbaum, DC; Matesan, M | 1 |
Barker, R; Bower, M; Chinn, R; Kazmi, F; Nelson, M; Ngan, S; O'Doherty, M; Stebbing, J | 1 |
Roca, B; Torres, V | 1 |
Ariga, T; Hatano, N; Itoh, T; Kawamura, N; Kubota, KC; Ohkura, Y; Okada, T; Okano, M; Sasaki, F; Takezaki, S; Toita, N; Yamada, M | 1 |
Alavi, A; Bertagna, F; Biasiotto, G; Giubbini, R; Rodella, R | 1 |
El-Osta, H; Janku, F; Kurzrock, R | 1 |
Choe, YH; Jeon, CJ; Kim, KM; Kim, MJ; Kong, DS; Lee, JH; Lee, JS; Shin, HJ; Suh, YL | 1 |
Inomata, S; Kanata, T; Nakamura, N; Sawazumi, T; Takahashi, H; Uehara, Y | 1 |
Graham, MM; Reddy, MP | 1 |
Gerbaudo, VH | 1 |
Butori, C; Italiano, A; Mouroux, J; Thyss, A; Verge, M | 1 |
Elliott, P; Hicks, R; Prince, HM; Ramdave, S; Robinson, H; Seymour, JF | 1 |
Aozasa, K; Enomoto, K; Hamada, K; Hatazawa, J; Higuchi, I; Hoshida, Y; Inoue, A; Kubo, T; Mizuki, M; Nakamichi, I; Sekimoto, M | 1 |
Camargo, EE; Cerri, GG; Etchebehere, EC; Lima, MC; Massumoto, CM; Mazo-Ruiz, MF; Mitteldorf, C; Ramos, CD; Rosa, MF; Santos, AO | 1 |
Capello, D; Capparella, V; Cianciulli, M; Emili, R; Falchi, L; Liberati, AM; Liberati, F; Pace, R; Palumbo, B; Rauco, A | 1 |
Bares, R; Horger, M; Müssig, K; Schöber, W; Wiefels, J | 1 |
Karwal, MW; Murphy, SP; Nathan, MA | 1 |
Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H; Yamaguchi, A | 1 |
Blockmans, D; Bobbaers, H; Maes, A; Mortelmans, L; Stroobants, S | 1 |
46 other study(ies) available for fluorodeoxyglucose f18 and Castleman Disease
Article | Year |
---|---|
Coexistence of primary hepatic myopericytoma and mediastinal Castleman disease in one patient: an interesting 18F-FDG PET/CT imaging case.
Topics: Castleman Disease; Fluorodeoxyglucose F18; Humans; Myopericytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Severe Inflammatory Idiopathic Multicentric Castleman's Disease Coexisting with Advanced Renal Cancer: A Case Report.
Topics: Aged; Castleman Disease; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male | 2022 |
Topics: Adult; Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Colonic Castleman Disease on FDG PET/CT.
Topics: Aged; Castleman Disease; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18 F-FDG PET/CT.
Topics: Castleman Disease; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2023 |
Topics: Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
Adrenal Castleman Disease on 99mTc-HYNIC-TOC Scan and FDG PET/CT.
Topics: Adrenal Gland Diseases; Aged; Castleman Disease; Fluorodeoxyglucose F18; Humans; Male; Octreotide; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography | 2021 |
68Ga-DOTATATE and 18F-FDG in Castleman Disease.
Topics: Adult; Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2020 |
A 10-year observational single-center study of retroperitoneal unicentric Castleman disease.
Topics: Adrenal Gland Neoplasms; Adult; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Interleukin-6; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retroperitoneal Space; Retrospective Studies; Treatment Outcome; Ultrasonography | 2021 |
18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.
Topics: Adult; Aged; Castleman Disease; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
Topics: Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retroperitoneal Space; Retrospective Studies; Thorax | 2021 |
Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
Topics: Castleman Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Ultrasonography | 2021 |
Coexistence of Mediastinal Castleman Disease with Spindle Cell Carcinoma of the Lung.
Topics: Aged; Carcinoma; Castleman Disease; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Surgical Procedures; Tomography, X-Ray Computed | 2017 |
Clinical utility of
Topics: Biopsy; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sialadenitis; Sjogren's Syndrome | 2018 |
[POEMS Syndrome].
Topics: Adult; Bone and Bones; Castleman Disease; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Guillain-Barre Syndrome; Humans; Image Interpretation, Computer-Assisted; Lymphography; Magnetic Resonance Imaging; Male; Middle Aged; Pleural Effusion; POEMS Syndrome; Positron Emission Tomography Computed Tomography; Prognosis; Spine; Tomography, X-Ray Computed | 2018 |
Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on 18F-FDG PET/CT: A case report.
Topics: Carcinoma, Hepatocellular; Castleman Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
Topics: Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pemphigus; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
Topics: Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Octreotide; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
FDG PET/CT Findings in TAFRO Syndrome.
Topics: Aged; Biopsy; Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Interleukin-6; Positron Emission Tomography Computed Tomography | 2018 |
A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
Topics: Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Octreotide; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin | 2019 |
Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clinical implication.
Topics: Aged; Biological Transport; Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2013 |
Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Castleman's disease in the retroperitoneal space mimicking a paraspinal schwannoma: a case report.
Topics: Adult; Angiography; Castleman Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neurilemmoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retroperitoneal Space; Spinal Neoplasms; Tomography, X-Ray Computed | 2013 |
Widespread hypermetabolic lesions due to multicentric form of Castleman disease as the cause of fever of unknown origin revealed by FDG PET/CT.
Topics: Castleman Disease; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neck; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Multicentric Castleman disease mimicking IgG4-related disease: A case report.
Topics: Autoimmune Diseases; Biopsy; C-Reactive Protein; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypergammaglobulinemia; Immunoglobulin G; Interleukin-6; Lymph Nodes; Middle Aged; Plasma Cells; Positron-Emission Tomography | 2017 |
18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
Topics: Adult; C-Reactive Protein; Castleman Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Salivary Glands; Sarcoma, Kaposi; Spleen | 2015 |
Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome.
Topics: Adult; Castleman Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron Emission Tomography Computed Tomography; Syndrome; Thrombocytopenia | 2017 |
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
Topics: Adult; Anti-Retroviral Agents; Castleman Disease; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymph Nodes; Lymphoproliferative Disorders; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 2009 |
Castleman's disease presenting as fever of unknown origin: diagnostic value of fluorodeoxyglucose-positron emission tomography/computed tomography.
Topics: Castleman Disease; Female; Fever; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
A 5-year-old boy with unicentric Castleman disease affecting the mesentery: utility of serum IL-6 level and (18)F-FDG PET for diagnosis.
Topics: Castleman Disease; Child, Preschool; Fever; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Interleukin-6; Lymph Node Excision; Male; Mesentery; Plasma Cells; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.
Topics: Adult; Castleman Disease; Fluorodeoxyglucose F18; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Kaposi; Tomography, X-Ray Computed | 2010 |
Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra).
Topics: Blood Cell Count; Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Interleukin 1 Receptor Antagonist Protein; Middle Aged; Positron-Emission Tomography; Whole Body Imaging | 2010 |
Castleman's disease associated with a cerebellar chordoid meningioma and intestinal lymphangiectasia.
Topics: Adolescent; Biopsy; Castleman Disease; Cerebellar Neoplasms; Cerebellum; Colon; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphangiectasis, Intestinal; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Microscopy, Electron; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
[Hyaline vascular-type Castleman disease of the pulmonary hilum that expanded during two years].
Topics: Adolescent; Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Hyalin; Lung; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
FDG positron emission tomographic imaging of thoracic Castleman's disease.
Topics: Castleman Disease; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed | 2003 |
18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero...
Topics: Castleman Disease; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[Fortuitous diagnosis of Castleman's disease by FDG-PET Scan during the follow-up of a renal cancer patient].
Topics: Adenocarcinoma; Castleman Disease; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2005 |
Preliminary experience of 18F-fluorodeoxyglucose positron emission tomography in Castleman's disease.
Topics: Adolescent; Adult; Aged; Castleman Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Unicentric and multicentric Castleman's disease.
Topics: Adult; Castleman Disease; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
Topics: Aged; Bone Marrow Diseases; Castleman Disease; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Castleman Disease; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Hyalin; Immunologic Factors; Plasma Cells; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[Imaging findings of angiofollicular lymphoid hyperplasia (Castleman's disease)].
Topics: Castleman Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2007 |
FDG-PET appearance of pelvic Castleman's disease.
Topics: Adult; Castleman Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Pelvic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma.
Topics: Castleman Disease; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Mesentery; Middle Aged; Peritoneal Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2001 |
FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation.
Topics: Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |